Crossmark

<scp>ASO</scp> targeting <scp>RBM3</scp> temperature‐controlled poison exon splicing prevents neurodegeneration <i>in vivo</i>

Crossref DOI link: https://doi.org/10.15252/emmm.202217157

Published Online: 2023-03-22

Published Print: 2023-05-08

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Preußner, Marco https://orcid.org/0000-0001-5155-0844
Smith, Heather L

Hughes, Daniel https://orcid.org/0000-0002-9706-5163
Zhang, Min

Emmerichs, Ann‐Kathrin

Scalzitti, Silvia

Peretti, Diego

Swinden, Dean

Neumann, Alexander

Haltenhof, Tom

Mallucci, Giovanna R https://orcid.org/0000-0001-8504-1191
Heyd, Florian https://orcid.org/0000-0001-9377-9882
Funding

Funding for this research was provided by:

Freie Universität Berlin

UK Dementia Research Institute (UKDRI‐2001)

Medical Research Council (MRC MC_U132692719)
License Information

Version of Record valid from 2023-03-22
More Information

Publication History

Received: 2022-11-09

Accepted: 2023-02-18

Published: 2023-03-22